NFE2L2 and non-small cell lung carcinoma: To examine whether Nestin knockdown accelerated Nrf2 degradation by increasing its ubiquitination via the ubiquitin–proteasome pathway, we treated NSCLC cells with the proteasome inhibitor, MG132.